The DOI matches its Crossref record; 78 of the 78 references it cites were found in a registry or an index.
Neutrophil-to-lymphocyte ratio, past, present and future perspectives
Open accessAbstract
In the review we analyzed short history of the establishment of a novel hematological parameter for systemic inflammation and stress coined as a neutrophil to lymphocyte ratio (NLR). Today NLR is widely used across almost all medical disciplines as a reliable and easy available marker of immune response to various infectious and non-infectious stimuli. We analyzed the immunological and biological aspects of dynamic changes of neutrophil granulocytes and lymphocytes in circulating blood during endocrine stress, dysbalance of autonomic nervous system and systemic inflammation. NLR reflects online dynamic relationship between innate (neutrophils) and adaptive cellular immune response (lymphocytes) during illness and various pathological states. NLR is influenced by many conditions including age, rice, medication, chronic disease like coronary heart disease, stroke, diabetes, obesity, psychiatric diagnosis, cancer of solid organs, anemia and stress. A normal range of NLR is between 1-2, the values higher than 3.0 and below 0.7 in adults are pathological. NLR in a grey zone between 2.3-3.0 may serve as early warning of pathological state or process such like cancer, atherosclerosis, infection, inflammation, psychiatric disorders and stress. NLR is used as a reliable and cheap marker of ongoing cancer-related inflammation and a valid indicator of prognosis of solid tumors. Majority of meta-analyses have explored the prognostic value of NLR in various solid tumors and have found out the cut-off value of NLR above 3.0 (IQR 2.5-5.0). We summarized its privilege in oncology: NLR may be used for stratification of cancer, correlates with the tumor size, stage of tumors, metastatic potential and lymphatic invasion. NLR has independent prognostic role regarding overall, cancer free and cancer-specific survival. It is useful for monitoring oncological therapy, including biological and immune check point inhibitors treatment. NLR is a very sensitive indicator of infection, inflammation and sepsis, validated in numerous studies. Clinical research confirmed the sensitivity of NLR for diagnosis/stratification of systemic infection, sepsis, bacteremia as well as its robust predictive and prognostic value. NLR should be investigated daily, and follow-up its absolute values and dynamic course in acute disease or critical illness. The severity of critical illness, the level of stress and serious inflammation is expressed by dramatic increasing of NLR values above 11 ≥ 17, or even higher than 30. Improving the clinical course of sepsis, critical illness, lower risk of mortality are associated with decline of NLR values below 7. NLR is helpful in differentiating more severe disease versus milder one. NLR is cheap, simple, fast responding and easy available parameter of stress and inflammation with high sensitivity and low specificity, it should be used routinely in emergency departments, ICUs, in acute medicine including surgery, orthopedics, traumatology, cardiology, neurology, psychiatry and even oncology. Dynamic changes of NLR precede the clinical state for several hours and may warn clinicians about the ongoing pathological process early. NLR is a novel perspective marker of cellular immune activation, a valid index of stress and systemic inflammation, which open a new dimension for clinical medicine, for better understanding of the biology of inflammation, coupling and antagonism between innate and adaptive immunity and its clinical consequences for health and disease (Tab. 8, Fig. 3, Ref. 151). Keywords: neutrophil-to-lymphocyte ratio, systemic inflammation, immune-inflammatory response, endocrinne stress.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Retracted: Neutrophil/lymphocyte ratio—A marker of COVID‐19 pneumonia severity
(2020) · doi:10.1111/ijcp.13698 · Cited by 88
RetractedBone, R. C., Balk, R. A., Cerra, F. B., Dellinger, R. P., Fein, A. M., Knaus, W. A., Schein, R. M. H., & Sibbald, W. J. (1992) · Chest · doi:10.1378/chest.101.6.1644 · Cited by 13,198
Mantovani, A., Allavena, P., Sica, A., & Balkwill, F. (2008) · Nature · doi:10.1038/nature07205 · Cited by 11,399
Immunity, Inflammation, and Cancer
Grivennikov, S. I., Greten, F. R., & Karin, M. (2010) · Cell · doi:10.1016/j.cell.2010.01.025 · Cited by 10,755
Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability
Colotta, F., Allavena, P., Sica, A., Garlanda, C., & Mantovani, A. (2009) · Carcinogenesis · doi:10.1093/carcin/bgp127 · Cited by 2,890
The systemic inflammation-based neutrophil–lymphocyte ratio: Experience in patients with cancer
Guthrie, G. J. K., Charles, K. A., Roxburgh, C. S. D., Horgan, P. G., McMillan, D. C., & Clarke, S. J. (2013) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2013.03.010 · Cited by 1,552
Liu, J., Liu, Y., Xiang, P., Pu, L., Xiong, H., Li, C., Zhang, M., Tan, J., Xu, Y., Song, R., et al. (2020) · Journal of Translational Medicine · doi:10.1186/s12967-020-02374-0 · Cited by 1,082
Tamhane, U. U., Aneja, S., Montgomery, D., Rogers, E.-K., Eagle, K. A., & Gurm, H. S. (2008) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2008.05.006 · Cited by 900
What is the normal value of the neutrophil-to-lymphocyte ratio?
Forget, P., Khalifa, C., Defour, J.-P., Latinne, D., Van Pel, M.-C., & De Kock, M. (2017) · BMC Research Notes · doi:10.1186/s13104-016-2335-5 · Cited by 841
Ethier, J.-L., Desautels, D., Templeton, A., Shah, P. S., & Amir, E. (2017) · Breast Cancer Research · doi:10.1186/s13058-016-0794-1 · Cited by 673
Systemic inflammatory response predicts survival following curative resection of colorectal cancer
McMillan, D. C., Canna, K., & McArdle, C. S. (2003) · British Journal of Surgery · doi:10.1002/bjs.4038 · Cited by 454
Motomura, T., Shirabe, K., Mano, Y., Muto, J., Toshima, T., Umemoto, Y., Fukuhara, T., Uchiyama, H., Ikegami, T., Yoshizumi, T., et al. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2012.08.017 · Cited by 448
Halazun, K. J., Aldoori, A., Malik, H. Z., Al-Mukhtar, A., Prasad, K. R., Toogood, G. J., & Lodge, J. P. A. (2008) · European Journal of Surgical Oncology (EJSO) · doi:10.1016/j.ejso.2007.02.014 · Cited by 444
Ferrucci, P. F., Ascierto, P. A., Pigozzo, J., Del Vecchio, M., Maio, M., Antonini Cappellini, G. C., Guidoboni, M., Queirolo, P., Savoia, P., Mandalà, M., et al. (2016) · Annals of Oncology · doi:10.1093/annonc/mdw016 · Cited by 395
Azab, B., Camacho-Rivera, M., & Taioli, E. (2014) · PLoS ONE · doi:10.1371/journal.pone.0112361 · Cited by 375
Neutrophil/lymphocyte ratio and platelet/lymphocyte ratio in mood disorders: A meta-analysis
Mazza, M. G., Lucchi, S., Tringali, A. G. M., Rossetti, A., Botti, E. R., & Clerici, M. (2018) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2018.03.012 · Cited by 326
Mei, Z., Shi, L., Wang, B., Yang, J., Xiao, Z., Du, P., Wang, Q., & Yang, W. (2017) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2017.05.005 · Cited by 304
Exploring the prognostic value of the neutrophil-to-lymphocyte ratio in cancer
Howard, R., Kanetsky, P. A., & Egan, K. M. (2019) · Scientific Reports · doi:10.1038/s41598-019-56218-z · Cited by 296
Lee, J. S., Kim, N. Y., Na, S. H., Youn, Y. H., & Shin, C. S. (2018) · Medicine · doi:10.1097/md.0000000000011138 · Cited by 289
Neutrophil-Lymphocyte Ratio as a Predictor of Adverse outcomes of Acute Pancreatitis
Azab, B., Jaglall, N., Atallah, J. P., Lamet, A., Raja-Surya, V., Farah, B., Lesser, M., & Widmann, W. D. (2011) · Pancreatology · doi:10.1159/000331494 · Cited by 282
Pichler, M., Hutterer, G. C., Stoeckigt, C., Chromecki, T. F., Stojakovic, T., Golbeck, S., Eberhard, K., Gerger, A., Mannweiler, S., Pummer, K., et al. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.28 · Cited by 275
Elevated neutrophil to lymphocyte ratio predicts survival in advanced pancreatic cancer
An, X., Ding, P.-R., Li, Y.-H., Wang, F.-H., Shi, Y.-X., Wang, Z.-Q., He, Y.-J., Xu, R.-H., & Jiang, W.-Q. (2010) · Biomarkers · doi:10.3109/1354750x.2010.491557 · Cited by 244
Stage-dependent alterations of the serum cytokine pattern in colorectal carcinoma
Kantola, T., Klintrup, K., Väyrynen, J. P., Vornanen, J., Bloigu, R., Karhu, T., Herzig, K.-H., Näpänkangas, J., Mäkelä, J., Karttunen, T. J., et al. (2012) · British Journal of Cancer · doi:10.1038/bjc.2012.456 · Cited by 241
Heffernan, D. S., Monaghan, S. F., Thakkar, R. K., Machan, J. T., Cioffi, W. G., & Ayala, A. (2012) · Critical Care · doi:10.1186/cc11157 · Cited by 229
Liu, X., Shen, Y., Wang, H., Ge, Q., Fei, A., & Pan, S. (2016) · Mediators of Inflammation · doi:10.1155/2016/8191254 · Cited by 227
Salciccioli, J. D., Marshall, D. C., Pimentel, M. A., Santos, M. D., Pollard, T., Celi, L. A., & Shalhoub, J. (2015) · Critical Care · doi:10.1186/s13054-014-0731-6 · Cited by 222
Ljungström, L., Pernestig, A.-K., Jacobsson, G., Andersson, R., Usener, B., & Tilevik, D. (2017) · PLOS ONE · doi:10.1371/journal.pone.0181704 · Cited by 219
Improved Early Detection of Sepsis in the ED With a Novel Monocyte Distribution Width Biomarker
Crouser, E. D., Parrillo, J. E., Seymour, C., Angus, D. C., Bicking, K., Tejidor, L., Magari, R., Careaga, D., Williams, J., Closser, D. R., et al. (2017) · Chest · doi:10.1016/j.chest.2017.05.039 · Cited by 216
Parallels between Cancer and Infectious Disease
Hotchkiss, R. S., & Moldawer, L. L. (2014) · New England Journal of Medicine · doi:10.1056/nejmcibr1404664 · Cited by 201
The Effect of Sepsis on the Erythrocyte
Bateman, R., Sharpe, M., Singer, M., & Ellis, C. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18091932 · Cited by 196
Mazza, M. G., Lucchi, S., Rossetti, A., & Clerici, M. (2020) · The World Journal of Biological Psychiatry · doi:10.1080/15622975.2019.1583371 · Cited by 191
The Hematologic System as a Marker of Organ Dysfunction in Sepsis
Aird, W. C. (2003) · Mayo Clinic Proceedings · doi:10.4065/78.7.869 · Cited by 170
Tomita, M., Shimizu, T. M., Ayabe, T., Yonei, A., & Onitsuka, T. (2011) · PubMed · Cited by 165
Suppiah, A., Malde, D., Arab, T., Hamed, M., Allgar, V., Smith, A. M., & Morris-Stiff, G. (2013) · Journal of Gastrointestinal Surgery · doi:10.1007/s11605-012-2121-1 · Cited by 165
Neutrophil to Lymphocyte Ratio Predicts Poor Prognosis in Ischemic Cerebrovascular Disease
Celikbilek, A., Ismailogullari, S., & Zararsiz, G. (2014) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.21639 · Cited by 165
Zaragoza, J., Caille, A., Bénéton, N., Bens, G., Christiann, F., Maillard, H., & Machet, L. (2015) · British Journal of Dermatology · doi:10.1111/bjd.14155 · Cited by 156
The complete blood count to diagnose septic shock
Farkas, J. D. (2020) · Journal of Thoracic Disease · doi:10.21037/jtd.2019.12.63 · Cited by 143
Kong, W., He, Y., Bao, H., Zhang, W., & Wang, X. (2020) · Disease Markers · doi:10.1155/2020/9731854 · Cited by 143
Bowen, R. C., Little, N. A. B., Harmer, J. R., Ma, J., Mirabelli, L. G., Roller, K. D., Breivik, A. M., Signor, E. A., Miller, A. B., & Khong, H. T. (2017) · Oncotarget · doi:10.18632/oncotarget.16291 · Cited by 141
Evaluation of potential biomarkers for the discrimination of bacterial and viral infections
Chalupa, P., Beran, O., Herwald, H., Kaspříková, N., & Holub, M. (2011) · Infection · doi:10.1007/s15010-011-0126-4 · Cited by 137
Yu, Y., Qian, L., & Cui, J. (2017) · Molecular and Clinical Oncology · doi:10.3892/mco.2017.1342 · Cited by 134
Followup of Neutrophil-to-Lymphocyte Ratio and Recurrence of Clear Cell Renal Cell Carcinoma
Ohno, Y., Nakashima, J., Ohori, M., Gondo, T., Hatano, T., & Tachibana, M. (2011) · The Journal of Urology · doi:10.1016/j.juro.2011.10.026 · Cited by 131
Akıllı, N. B., Yortanlı, M., Mutlu, H., Günaydın, Y. K., Köylü, R., Akça, H. Ş., Akıncı, E., Dündar, Z. D., & Cander, B. (2014) · The American Journal of Emergency Medicine · doi:10.1016/j.ajem.2014.09.001 · Cited by 119
Acevedo, R. H. (2017) · The American Pharmacists Association eBooks · doi:10.21019/pharmacotherapyfirst.septic-shock_overview · Cited by 88
Redistribution of lymphocytes after major surgical stress
Toft, P., Patricio Xavier Duran, S., Tønnesen, E., Rasmussen, J. W., & Christensen, N. J. (1993) · Acta Anaesthesiologica Scandinavica · doi:10.1111/j.1399-6576.1993.tb03708.x · Cited by 86
Effects of surgical trauma of laparoscopic vs. open cholecystectomy.
Dionigi, R., Dominioni, L., Benevento, A., Giudice, G., Cuffari, S., Bordone, N., Caravati, F., Carcano, G., & Gennari, R. (1994) · PubMed · Cited by 82
The Neutrophil to Lymphocyte Ratio on Admission and Short-Term Outcomes in Orthogeriatric Patients
Fisher, A., Srikusalanukul, W., Fisher, L., & Smith, P. N. (2016) · International Journal of Medical Sciences · doi:10.7150/ijms.15445 · Cited by 79
Acartürk, G., Acay, A., Demir, K., Mennune Sena, U. L. U., Ahsen, A., & Yüksel, Ş. (2015) · Bratislavské lekárske listy/Bratislava medical journal · doi:10.4149/bll_2015_041 · Cited by 77
Ishizuka, M., Oyama, Y., Abe, A., & Kubota, K. (2014) · Journal of Surgical Oncology · doi:10.1002/jso.23753 · Cited by 75
Diagnostic and Prognostic Role of Neutrophil-to-Lymphocyte Ratio in Early and Late Phase of Sepsis
Sharma, M., Jain, N., Sinha, N., Kaushik, R., Jash, D., & Chaudhry, A. (2018) · Indian Journal of Critical Care Medicine · doi:10.4103/ijccm.ijccm_59_18 · Cited by 71
Sari, R., Karakurt, Z., Ay, M., ÇELİK, M. E., Tekan, Ü. Y., Çiyiltepe, F., Kargın, F., Saltürk, C., Moçin, Ö. Y., Güngör, G., et al. (2019) · TURKISH JOURNAL OF MEDICAL SCIENCES · doi:10.3906/sag-1901-105 · Cited by 71
Canakinumab as treatment for COVID-19-related pneumonia: A prospective case-control study
Generali, D., Bosio, G., Malberti, F., Antonio, C., Testa, S., Romanini, L., Fioravanti, A., Morandini, A., Pianta, L., Giannotti, G., et al. (2020) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2020.12.073 · Cited by 65
Marik, P. E., & Stephenson, E. (2020) · Journal of Critical Care · doi:10.1016/j.jcrc.2020.07.026 · Cited by 63
Jankova, L., Dent, O. F., Chan, C., Chapuis, P. H., & Clarke, S. J. (2013) · BMC Cancer · doi:10.1186/1471-2407-13-442 · Cited by 49
Novel Biomarkers for Personalized Cancer Immunotherapy
Shindo, Y., Hazama, S., Tsunedomi, R., Suzuki, N., & Nagano, H. (2019) · Cancers · doi:10.3390/cancers11091223 · Cited by 49
Arigami, T., Uenosono, Y., Matsushita, D., Yanagita, S., Uchikado, Y., Kita, Y., Mori, S., Kijima, Y., Okumura, H., Maemura, K., et al. (2015) · Oncology Letters · doi:10.3892/ol.2015.4049 · Cited by 46
Is the Neutrophil-to-Lymphocyte Ratio a Useful Prognostic Indicator in Melanoma Patients?
Cohen, J. T., Miner, T. J., & Vezeridis, M. P. (2020) · Melanoma Management · doi:10.2217/mmt-2020-0006 · Cited by 46
Ni, A. (2016) · Journal of Blood & Lymph · doi:10.4172/2165-7831.1000143 · Cited by 43
Novel Mortality Markers for Critically Ill Patients
Yoldaş, H., Karagöz, İ., Öğün, M. N., Velioğlu, Y., Yıldız, İ., Bilgi, M., & Demırhan, A. (2018) · Journal of Intensive Care Medicine · doi:10.1177/0885066617753389 · Cited by 43
Szkandera, J., Gerger, A., Liegl‐Atzwanger, B., Stotz, M., Samonigg, H., Friesenbichler, J., Stojaković, T., Leithner, A., & Pichler, M. (2014) · The American Journal of Surgery · doi:10.1016/j.amjsurg.2014.10.021 · Cited by 42
Rationale Use of Neutrophil-to-lymphocyte ratio for early diagnosis and stratification of COVID-19
Záhorec, R., Hulín, I., & Záhorec, P. (2020) · Bratislavské lekárske listy/Bratislava medical journal · doi:10.4149/bll_2020_077 · Cited by 39
Qiu, L., Xu, J., Wang, J., Tang, X.-D., Fang, X., Li, S.-J., Wang, F., & Chen, X. (2021) · Journal of Inflammation Research · doi:10.2147/jir.s294543 · Cited by 31
Prognostic Impact of the Neutrophil-to-Lymphocyte Ratio in Stage I-II Rectal Cancer Patients
Yoshida, D., Minami, K., Sugiyama, M., Ota, M., Ikebe, M., Morita, M., Matsukuma, A., & Toh, Y. (2019) · Journal of Surgical Research · doi:10.1016/j.jss.2019.07.072 · Cited by 30
Zhou, T., Zheng, N., Li, X., Zhu, D., & Han, Y. (2021) · BMC Emergency Medicine · doi:10.1186/s12873-021-00418-2 · Cited by 29
Sun, X., Wang, J., Liu, J., Chen, S., & Liu, X. (2016) · OncoTargets and Therapy · doi:10.2147/ott.s108631 · Cited by 26
Reiske, L., Schmucker, S. S., Pfaffinger, B., Weiler, U., Steuber, J., & Stefanski, V. (2020) · The Journal of Immunology · doi:10.4049/jimmunol.2000269 · Cited by 26
Güçyetmez, B., & Atalan, H. K. (2016) · PLoS ONE · doi:10.1371/journal.pone.0148699 · Cited by 20
Wang, Z., Tian, S., Zhao, K., Zhang, R., Yin, Y., Zhu, Y., Hou, Z., & Zhang, Y. (2020) · International Orthopaedics · doi:10.1007/s00264-020-04793-6 · Cited by 19
Infection markers as predictors of Bacteremia in an Intensive Care Unit: A prospective study
Şen, P., Demırdal, T., Nemli, S. A., Vardar, İ., Kizilkaya, M., Şencan, A., & Yılmaz, H. E. (2018) · Pakistan Journal of Medical Sciences · doi:10.12669/pjms.346.15665 · Cited by 12
An enrichment model using regular health examination data for early detection of colorectal cancer
Shi, Q., Gao, Z., Wu, P., Heng, F., Lei, F., Wang, Y., Gao, Q., Zeng, Q., Niu, P., Li, C., et al. (2019) · Chinese Journal of Cancer Research · doi:10.21147/j.issn.1000-9604.2019.04.12 · Cited by 11
Chen, Z., Yu, X., Mao, L., Zheng, R., Xue, L., Shu, J., Luo, Z., & Pan, J. (2020) · Clinical & Translational Oncology · doi:10.1007/s12094-020-02405-8 · Cited by 11
Štrumfa, I., Bogdanova, T., Kalva, A., Štrumfs, B., Rumba, R., Vanags, A., Drike, I., Mezale, D., Āboliņš, A., Jakovļevs, A., et al. (2017) · InTech eBooks · doi:10.5772/intechopen.69723 · Cited by 7
A new interpretation of neutrophil-lymphocyte ratio from psychiatric aspect
Kalelioğlu, T., & Karamustafalıoğlu, N. (2019) · Bratislavské lekárske listy/Bratislava medical journal · doi:10.4149/bll_2019_099 · Cited by 6
Clinical utility of neutrophil–lymphocyte ratio in the diagnosis of neuroleptic malignant syndrome
Karamustafalıoğlu, N., Kalelioğlu, T., Celikel, G., Genç, A., & Emül, M. (2019) · Nordic Journal of Psychiatry · doi:10.1080/08039488.2019.1623315 · Cited by 5
Ивановна, С. Е., Викторовна, П. И., Samatov, I. Y., Арнольдовна, В. В., & Верещагин, Е. И. (2020) · JOURNAL of SIBERIAN MEDICAL SCIENCES · doi:10.31549/2542-1174-2020-3-108-125 · Cited by 5
Orfanu, A. E., Popescu, C., Tilişcan, C., Streinu‐Cercel, A., Aramă, V., & Aramă, Ș. S. (2020) · Revista română de medicină de laborator · doi:10.2478/rrlm-2020-0002 · Cited by 3
Korkmaz, P., Erarslan, S., & Toka, O. (2017) · The Annals of Clinical and Analytical Medicine · doi:10.4328/jcam.4816 · Cited by 2
Pattern-recognition receptors and neutrophils in cancer inflammation
Millrud, C. R. (2013) · Figshare · Cited by 1
Cited by
Islam, M. M., Satici, M. O., & Eroglu, S. E. (2024) · Turkish Journal of Emergency Medicine · doi:10.4103/tjem.tjem_198_23 · Cited by 255
Zheng, Q., Liu, J., Ji, Y., Zhang, Y., Chen, X., & Liu, B. (2022) · BMC Psychiatry · doi:10.1186/s12888-022-04260-z · Cited by 26
Gui, L., Yu, H., Wei, Y., Huang, Q., Liu, Y., & Fu, Y. (2025) · The European Journal of Psychiatry · doi:10.1016/j.ejpsy.2025.100308 · Cited by 4
Metadata
- Authors
- Zahorec, R.
- Venue
- Bratislava Medical Journal
- Published
- 2021
- Volume
- 122
- Issue
- 07
- Pages
- 474-488
- ISSN
- 0006-9248 (ISSN-L)
- 1336-0345
- OpenAlex
- W3176364966
- Cited by
- 885
- References
- 78
- FWCI
- 39.38
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.